军事医学
軍事醫學
군사의학
BULLETIN OF THE ACADEMY OF MILITARY MEDICAL SCIENCES
2014年
7期
518-522
,共5页
徐清波%丁晓然%杜丽娜%鲁丹丹%金义光%王升启
徐清波%丁曉然%杜麗娜%魯丹丹%金義光%王升啟
서청파%정효연%두려나%로단단%금의광%왕승계
纳米粒%透膜肽%聚乳酸-羟基乙酸%反义寡核苷酸%缓释
納米粒%透膜肽%聚乳痠-羥基乙痠%反義寡覈苷痠%緩釋
납미립%투막태%취유산-간기을산%반의과핵감산%완석
nanoparticles%cell-penetrating peptides%PLGA%oligodeoxynucleotide%sustained release
目的:制备与评价包载反义核酸药物-流感泰得的透膜肽修饰的聚乳酸-羟基乙酸共聚物[poly(D,L-lactic-co-glycolic acid ),PLGA]纳米粒。方法通过固相多肽合成法合成透膜肽( trans-activating transcriptional acti-vator,TAT),使用高效液相色谱及质谱仪检测其纯度及相对分子质量。用TAT修饰PLGA后,采用双重乳化挥发溶剂法制备包载流感泰得的新型纳米粒,并对纳米粒进行理化分析和体外缓释效果评价,主要指标有:粒径、分散系数、Zeta电位、表面形态、载药量及体外释放。 Cell Count Kit-8(CCK-8)实验评价TAT-PLGA纳米粒的细胞毒性。结果合成的TAT纯度为95.6%,相对分子质量为1495.8,TAT修饰PLGA后所制备的纳米粒粒径为(159.5±2.1) nm,Zeta电位为-(1.87±0.6)mV,载药量为(5.75±0.17)μg/mg。在扫描电子显微镜下观察纳米粒形态为圆形,表面光滑,粒径分布均匀。体外释放实验结果显示TAT修饰的PLGA纳米粒包封的流感泰得具有缓释作用。细胞毒性实验结果显示,TAT修饰的PLGA纳米粒对细胞体外生长无不良影响,细胞相容性良好。结论通过固相多肽合成法成功合成了TAT,并成功使用双重乳化溶剂挥发法制备了TAT修饰的PLGA纳米粒,在流感预防与治疗方面具有潜在应用前景。
目的:製備與評價包載反義覈痠藥物-流感泰得的透膜肽脩飾的聚乳痠-羥基乙痠共聚物[poly(D,L-lactic-co-glycolic acid ),PLGA]納米粒。方法通過固相多肽閤成法閤成透膜肽( trans-activating transcriptional acti-vator,TAT),使用高效液相色譜及質譜儀檢測其純度及相對分子質量。用TAT脩飾PLGA後,採用雙重乳化揮髮溶劑法製備包載流感泰得的新型納米粒,併對納米粒進行理化分析和體外緩釋效果評價,主要指標有:粒徑、分散繫數、Zeta電位、錶麵形態、載藥量及體外釋放。 Cell Count Kit-8(CCK-8)實驗評價TAT-PLGA納米粒的細胞毒性。結果閤成的TAT純度為95.6%,相對分子質量為1495.8,TAT脩飾PLGA後所製備的納米粒粒徑為(159.5±2.1) nm,Zeta電位為-(1.87±0.6)mV,載藥量為(5.75±0.17)μg/mg。在掃描電子顯微鏡下觀察納米粒形態為圓形,錶麵光滑,粒徑分佈均勻。體外釋放實驗結果顯示TAT脩飾的PLGA納米粒包封的流感泰得具有緩釋作用。細胞毒性實驗結果顯示,TAT脩飾的PLGA納米粒對細胞體外生長無不良影響,細胞相容性良好。結論通過固相多肽閤成法成功閤成瞭TAT,併成功使用雙重乳化溶劑揮髮法製備瞭TAT脩飾的PLGA納米粒,在流感預防與治療方麵具有潛在應用前景。
목적:제비여평개포재반의핵산약물-류감태득적투막태수식적취유산-간기을산공취물[poly(D,L-lactic-co-glycolic acid ),PLGA]납미립。방법통과고상다태합성법합성투막태( trans-activating transcriptional acti-vator,TAT),사용고효액상색보급질보의검측기순도급상대분자질량。용TAT수식PLGA후,채용쌍중유화휘발용제법제비포재류감태득적신형납미립,병대납미립진행이화분석화체외완석효과평개,주요지표유:립경、분산계수、Zeta전위、표면형태、재약량급체외석방。 Cell Count Kit-8(CCK-8)실험평개TAT-PLGA납미립적세포독성。결과합성적TAT순도위95.6%,상대분자질량위1495.8,TAT수식PLGA후소제비적납미립립경위(159.5±2.1) nm,Zeta전위위-(1.87±0.6)mV,재약량위(5.75±0.17)μg/mg。재소묘전자현미경하관찰납미립형태위원형,표면광활,립경분포균균。체외석방실험결과현시TAT수식적PLGA납미립포봉적류감태득구유완석작용。세포독성실험결과현시,TAT수식적PLGA납미립대세포체외생장무불량영향,세포상용성량호。결론통과고상다태합성법성공합성료TAT,병성공사용쌍중유화용제휘발법제비료TAT수식적PLGA납미립,재류감예방여치료방면구유잠재응용전경。
Objective To prepare and evaluate flutide-loaded PLGA nanoparticles modified with cell-penetrating peptide-TAT.Methods The sequence of TAT was synthesized with florenl methyoxycarbonyl amino acids .The purity and molecular weight of TAT were determined using RP-HPLC and MALDI-TOF-MS.PLGA was modified with the TAT peptide and then prepared into flutide-loaded nanoparticles ( TAT-PLGA NPs) with the double emulsion method .The physical and chemical properties were evaluated , including size distribution, Zeta potential, SEM of nanoparticles , loading ratio of drug content and release profiles of TAT-PLGA NPs in vitro.The cytotoxicity of TAT-PLGA NPs was evaluated by CCK-8 methods.Results The purity of synthesized TAT was 95.6%, and molecular weight was 1495.8.The mean diameter,Zeta potential, drug loading ratio of TAT-PLGA nanoparticals were (159.5 ±2.1) nm, -(1.87 ±0.6) mV, and (5.75 ±0.17)μg/mg, respectively.The nanoparticles observed by transmission electron microscopy (TEM) had a spherical shape and uniform size without aggregation .In vitro release test showed sustained release of flutide from TAT-PLGA nanoparticles .Cell proliferation assay revealed that the TAT-PLGA nanoparticles did not damage the cell growth in vitro and showed good compatibility.Conclusion TAT-PLGA nanoparticles are prepared successfully by double emulsion method,and have sustained-release effect and good compatibility in vitro.They have potential application prospect in prevention and treatment of influenza .